# Peijia Medical and HighLife enter license agreement for mitral valve replacement in Greater China

Peijia Medical and HighLife SAS entered into a license agreement granting Peijia an exclusive license to manufacture, develop, and commercialize HighLife's TMVR products in Greater China, with upfront fee and milestone payments.

- Type: Contract
- Announced: 2020-12-21
- Where: Greater China, China
- Status: announced
- Products: transeptal mitral valve replacement system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Peijia Medical](https://endata.com/companies/52051.md) (partner)
- [HighLife SAS](https://endata.com/companies/52052.md) (partner)

## Sources

- [sofinnovapartners.com](https://www.sofinnovapartners.com/news/peijia-medical-and-highlife-enter-into-license-and-technology-transfer-agreement-for-transeptal-mitral-valve-replacement-in-greater-china), 2020-12-21: "Peijia Medical Ltd and HighLife SAS announced that they have entered into a license agreement pursuant to which HighLife has granted to Peijia an exclusive license regarding certain proprietary TMVR products currently in development by the Licensor."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.